ATE419246T1 - Als antagonisten des muscarinrezeptors geeignete xanthinderivate - Google Patents

Als antagonisten des muscarinrezeptors geeignete xanthinderivate

Info

Publication number: ATE419246T1
Authority: AT; Austria
Prior art keywords: xanthine derivatives; antagonists; derivatives suitable; muscarine receptor; disclosed compounds
Prior art date: 2004-06-16

Application number

AT04743765T

Other languages

English (en)

Inventor

Anita Mehta

Mohammad Salman

Pakala Sarma

Anita Chugh

Suman Gupta

Original Assignee

Ranbaxy Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-16

Filing date

2004-06-16

Publication date

2009-01-15

2004-06-16 Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd

2009-01-15 Application granted granted Critical

2009-01-15 Publication of ATE419246T1 publication Critical patent/ATE419246T1/de

Links

LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title abstract 2
229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title abstract 2
239000005557 antagonist Substances 0.000 title 1
102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 2
108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000001404 mediated effect Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
210000005095 gastrointestinal system Anatomy 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000000241 respiratory effect Effects 0.000 abstract 1
230000002485 urinary effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT04743765T 2004-06-16 2004-06-16 Als antagonisten des muscarinrezeptors geeignete xanthinderivate ATE419246T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IB2004/002004 WO2006005980A1 (en)	2004-06-16	2004-06-16	Xanthine derivatives useful as muscarinic receptor antagonists

Publications (1)

Publication Number	Publication Date
ATE419246T1 true ATE419246T1 (de)	2009-01-15

Family

ID=35783548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04743765T ATE419246T1 (de)	2004-06-16	2004-06-16	Als antagonisten des muscarinrezeptors geeignete xanthinderivate

Country Status (5)

Country	Link
US (1)	US20080319002A1 (de)
EP (1)	EP1765809B1 (de)
AT (1)	ATE419246T1 (de)
DE (1)	DE602004018844D1 (de)
WO (1)	WO2006005980A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5656288B2 (ja) *	2007-09-07	2015-01-21	セラヴァンスバイオファーマアール＆ディーアイピー，エルエルシー	ムスカリン受容体アンタゴニストとして有用なグアジニン含有化合物
WO2009041646A1 (ja)	2007-09-28	2009-04-02	Asahi Glass Company, Limited	光硬化性組成物、微細パターン形成体の製造方法および光学素子
EP2222637A1 (de)	2007-12-14	2010-09-01	Theravance, Inc.	Amidinhaltige verbindungen als muscarinrezeptor-antagonisten

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL124473C (de) *	1960-07-26
IT8721978A0 (it) *	1987-09-21	1987-09-21	Angeli Inst Spa	Nuovi derivati ammidinici triciclici.
US5001160A (en) *	1988-04-28	1991-03-19	Marion Laboratories, Inc.	1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
US5281601A (en) *	1989-12-12	1994-01-25	Pfizer Inc.	Muscarinic receptor antagonists
GB9020051D0 (en) *	1990-09-13	1990-10-24	Pfizer Ltd	Muscarinic receptor antagonists
US5889006A (en) *	1995-02-23	1999-03-30	Schering Corporation	Muscarinic antagonists
CA2179574A1 (en) *	1995-06-26	1996-12-27	Tomomi Okada	Substituted piperidine derivative and medicine comprising the same
DE69615214T2 (de) *	1995-10-13	2002-06-27	Banyu Pharmaceutical Co., Ltd.	Substituierte heteroaromatische derivate
PE92198A1 (es) *	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AU2002314744A1 (en) *	2001-04-17	2002-10-28	Sepracor, Inc.	Thiazole and other heterocyclic ligands and use thereof
CA2511726A1 (en) *	2002-12-23	2004-07-08	Ranbaxy Laboratories Limited	Xanthine derivatives as muscarinic receptor antagonists

2004
- 2004-06-16 US US11/570,749 patent/US20080319002A1/en not_active Abandoned
- 2004-06-16 EP EP04743765A patent/EP1765809B1/de not_active Expired - Lifetime
- 2004-06-16 AT AT04743765T patent/ATE419246T1/de not_active IP Right Cessation
- 2004-06-16 WO PCT/IB2004/002004 patent/WO2006005980A1/en not_active Ceased
- 2004-06-16 DE DE602004018844T patent/DE602004018844D1/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1765809A1 (de)	2007-03-28
DE602004018844D1 (de)	2009-02-12
WO2006005980A1 (en)	2006-01-19
EP1765809B1 (de)	2008-12-31
US20080319002A1 (en)	2008-12-25

Similar Documents

Publication	Publication Date	Title
DE60231341D1 (de)	2009-04-09	Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
EA200501595A1 (ru)	2006-06-30	Азабициклические производные в качестве антагонистов мускаринового рецептора
MY161834A (en)	2017-05-15	Substituted diazepan compounds as orexin receptor antagonists
ATE477252T1 (de)	2010-08-15	Substituierte diazepane als antagonisten an orexinrezeptoren
EA201170624A1 (ru)	2011-12-30	Изоникотинамидные антагонисты рецепторов орексинов
UA100974C2 (ru)	2013-02-25	Соединения замещенных диазепанов как антагонисты орексиновых рецепторов
JO2645B1 (en)	2012-06-17	Vehicles
ATE542795T1 (de)	2012-02-15	Benzylpiperazinderivate als motilin- rezeptorantagonisten
EA200501593A1 (ru)	2006-06-30	Азабициклические производные в качестве антагонистов мускаринового рецептора
WO2007016087A3 (en)	2007-06-21	Heterocyclic benzodiazepine cgrp receptor antagonists
MX2007011847A (es)	2008-03-11	Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
EA200970553A1 (ru)	2009-10-30	Пиперидиниламинопиридазины и их применение в качестве быстро диссоциирующих антагонистов рецептора допамина 2
EA200501594A1 (ru)	2006-08-25	Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
WO2006120478A3 (en)	2007-03-29	Quinoline derivatives as neurokinin receptor antagonists
IS8377A (is)	2006-03-27	Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
WO2006035282A3 (en)	2006-05-18	Muscarinic receptor antagonists
WO2006044449A3 (en)	2006-11-23	Cgrp receptor antagonists
WO2006054162A8 (en)	2006-07-20	Azabicyclic muscarinic receptor antagonists
WO2006018708A3 (en)	2006-04-20	Pyrrolidine derivatives as muscarinic receptor antagonists
ATE419246T1 (de)	2009-01-15	Als antagonisten des muscarinrezeptors geeignete xanthinderivate
WO2008041184A3 (en)	2008-07-03	Muscarinic receptor antagonists
WO2006032994A3 (en)	2006-05-04	Muscarinic receptor antagonists
EA200801591A1 (ru)	2008-12-30	Антагонисты мускаринового рецептора
WO2007007281A3 (en)	2007-05-10	Muscarinic receptor antagonists
WO2008104942A3 (en)	2008-12-18	Muscarinic receptor antagonists

Legal Events

Date	Code	Title	Description
2009-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties